MedPath

Development of novel biomarkers for inflammatory bowel disease using HPLC

Not Applicable
Conditions
lcerative colitis Crohn&#39
s disease
Registration Number
JPRN-UMIN000033367
Lead Sponsor
Keio University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

Those who judged unsuitable

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Development of novel biomarkers for diagnosis of inflammatory bowel disease
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath